We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

012450:KRXHanwha Aerospace Co., Ltd. Analysis

Data as of 2026-05-28 - not real-time

₩1,200,000.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hanwha Aerospace is trading around KRW 1.20 million, just above the 20‑day SMA and near its technical support at KRW 1.181 million. The RSI sits at roughly 35, indicating modest oversold pressure, while the MACD remains bearish, suggesting short‑term downside momentum. Volatility is elevated at about 47 % over the past 30 days, yet the stock’s beta is low (≈0.24), implying limited market‑wide risk. Fundamentally, the company posted ~5 % revenue growth YoY and a solid operating margin, but carries a high debt‑to‑equity ratio (~91 %) and negative free cash flow, while the DCF‑derived fair value of KRW 405 k is far below the current price, flagging significant overvaluation. On the positive side, the recent announcement of an additional stake in Korea Aerospace Industries points to strategic consolidation in the aerospace‑defense arena, and a modest dividend yield of 0.56 % with a payout ratio under 22 % supports dividend sustainability.
Overall, the stock sits in a neutral technical zone with bearish momentum, is materially overvalued relative to intrinsic estimates, but benefits from a defensive sector backdrop and strategic growth initiatives that could underpin longer‑term stability.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram and proximity to technical resistance
  • Significant overvaluation versus DCF fair value
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic acquisition of additional KAI shares
  • Stable dividend payout and modest revenue growth
  • Continued high debt load limiting upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Defensive aerospace & defense sector fundamentals
  • Potential upside from defense spending and space initiatives
  • Persistent overvaluation and cash flow constraints

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin5.96%
P/E Ratio21.4
ROE18.46%
ROA3.97%
Debt/Equity91.24
Op. Cash Flow₩2503.0B
Free Cash Flow₩-808671772672
Industry P/E30.1

Technical Analysis

TrendNeutral
RSI35.5
Support₩1,181,000.00
Resistance₩1,482,000.00
MA 20₩1,306,350.00
MA 50₩1,372,400.00
MA 200₩1,124,815.00
MACDBearish
VolumeDecreasing
Fear & Greed Index91.66

Valuation

Fair Value₩405,253.55
Target Price₩1,738,809.50
Upside/Downside44.90%
GradeOvervalued
TypeBlend
Dividend Yield0.56%

Risk Assessment

Beta0.24
Volatility47.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.